Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-190-0 | CAS number: 10058-44-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In accordance with Annex XI, Section 1.5 it is considered to be adequate and reliable to fulfil the information requirements for the endpoint ‘mutagenicity’ by applying a read-across approach from data generated on the substance iron orthophosphate (CAS # 10045-86-0). Both substances are relatively insoluble inorganic ferric (Fe3+) compounds. In conditions where the substances have limited solubility/bioavailability; ionisation to the Fe cation and the orthophosphate cation (iron orthophosphate) or pyrophosphate cation (tetrairon tris(pyrophosphate) will occur. In biological systems (i.e. in the presence of alkaline phosphatase) the pyrophosphate will be broken down into orthophosphate. It is considered that the Fe3+ cation is of most relevance when considering the genotoxic potential of the test material and as iron orthophosphate is slightly more soluble this substance is a good candidate for read-across.
Iron orthophosphate (also known as ferric phosphate) has previously been reviewed as an active substance for inclusion on Annex I of the Council Directive 91/414/EEC. Under this review, it was deemed not to be mutagenic. For the purpose of REACH the available data were reviewed and a weight of evidence approach has been used to fulfil the Annex IX requirements.
One study to assess the genetic toxicity to bacteria was available (Brusick, 1975). The study design was comparable to OECD 471, however, the study was lacking as it only considered 3 types of S. typhimurium and did not include strain designed to detect cross-linking mutagens and is therefore only considered to be a reliability 3 (not reliable) study.
A review of the toxicity of iron salts (Iron Nutritional and physiological significance, British Nutrition Foundation. Published by Chapman & Hall, 1995) suggests that iron salts can produce strand breaks in DNA when incubated with purified DNA or isolated mitochondria and iron overloaded rats show an increased number of strand breaks in hepatic DNA. It is theorised that the mechanism of strand-breakage involves iron-catalysed production of hydroxyl radicals which can abstract hydrogen atoms from both the ribose moiety and purine/pyrimidine bases. The oxidative/catalytic mechanisms responsible for these events require the presence of iron atoms with free coordination linkages and thus cannot be mediated by transferrin-bound iron, nor by iron resident within the core of ferritin. Consequently these potentially carcinogenic reactions are only likely to occur when iron levels exceed the binding capacity of ferritin to transferrin. Saturation of transferrin occurs only in severe iron overload and therefore under normal test conditions (e.g. a chromosome aberration study) it is anticipated that no indications of genetic toxicity would be observed.
Further, a study by Dunkel et al (1999) investigated the effects of iron orthophosphate on mammalian cells; this study was comparable to the current guideline (OECD 476). The results of this study were ambiguous – a weakly positive response was detected in those cells exposed to ferric phosphate with metabolic activation and as such a study according to OECD 476 and under the conditions of GLP was performed (Brown, 2011). In this study the test item did not induce any statistically significant or dose-related increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test.
As both iron and phosphate are essential nutrients and given that humans have been exposed to iron as a nutritional supplement for many years without report of iron-induced mutagenicity it is considered unlikely that relevant mutagenic effects in humans or other mammals might result from the occupation exposure and use of tetrairon tris(pyrophosphate) and therefore no further studies are proposedJustification for selection of genetic toxicity endpoint
No study was selected, since all data suggest that tetrairon tris(pyrophosphate) is not genotoxic.
Short description of key information:
In accordance with Annex XI, Section 1.5 it is considered to be adequate and reliable to fulfil the information requirements for the endpoint ‘mutagenicity’ by applying a read-across approach from data generated on the substance iron orthophosphate (CAS # 10045-86-0) and as such a number of studies are submitted.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Tetrairon tris(pyrophosphate) is considered to be non-mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.